Literature DB >> 22321220

Social adaptability index predicts overall mortality in patients with diabetes.

Alexander S Goldfarb-Rumyantzev1, Preeti Rout, Gurprataap S Sandhu, Anna Barenbaum, Bhanu K Patibandla, Akshita Narra, Varun Chawla, Mark Williams.   

Abstract

BACKGROUND: A quantifiable assessment of socioeconomic status and its bearing on clinical outcome in patients with diabetes is lacking. The social adaptability index (SAI) has previously been validated in the general population and in patients with chronic kidney disease, including those on dialysis and with kidney transplant. We hypothesize that SAI could be used in diabetes practice to identify a disadvantaged population at risk for inferior outcomes.
METHODS: The NHANES-3 database of patients who have diabetes was analyzed. The association of the SAI (calculated as the linear combination of indicators of education status, employment, income, marital status, and substance abuse) with patient survival was evaluated using Cox model.
RESULTS: The study population consisted of 1634 subjects with diabetes mellitus with mean age of 61.9±15.3 years; 40.9% males; 38.5% white, 27.7% African American, and 31.3% Mexican American. The highest SAI was in whites (6.9±2.5), followed by Mexican Americans (6.5±2.3), and then African Americans (6.1±2.6) (ANOVA, P<.001). SAI was higher in subjects living in metropolitan areas (6.8±2.6) compared to the rural population (6.3±2.4) (T test, P<.001). Also, SAI was greater in males (7.1±2.4) than in females (6.1±2.4) (T test, P<.001). SAI had significant association with survival (hazard ratio 0.9, P<.001) in the entire study population and in most of the subgroups (divided by race, sex, and urban/rural location). Furthermore, SAI divided into tertiles (≤5, 6 to 8, >8) demonstrated a significant and "dose-dependent" association with survival.
CONCLUSION: Social adaptability index is associated with mortality in the diabetic population and is useful in identifying individuals who are at risk for inferior outcomes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22321220     DOI: 10.1016/j.jdiacomp.2011.12.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

Review 1.  Type 2 diabetes and cardiovascular disease: what next?

Authors:  Joshua J Joseph; Sherita Hill Golden
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

2.  Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients.

Authors:  David J Taber; Mahsa Hamedi; James R Rodrigue; Mulugeta G Gebregziabher; Titte R Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939

3.  Social Adaptability Index and Pregnancy Outcomes in Women With Diabetes During Pregnancy.

Authors:  Anna Palatnik; Rebekah J Walker; Madhuli Y Thakkar; Leonard E Egede
Journal:  Diabetes Spectr       Date:  2021-03-16

4.  Use of social adaptability index to explain self-care and diabetes outcomes.

Authors:  Jennifer A Campbell; Rebekah J Walker; Brittany L Smalls; Leonard E Egede
Journal:  BMC Endocr Disord       Date:  2017-06-20       Impact factor: 2.763

5.  Association of Education and Smoking Status on Risk of Diabetes Mellitus: A Population-Based Nationwide Cross-Sectional Study.

Authors:  Jin-Hyeong Kim; Juhwan Noh; Jae-Woo Choi; Eun-Cheol Park
Journal:  Int J Environ Res Public Health       Date:  2017-06-19       Impact factor: 3.390

6.  Association Between Social Adaptability Index Score and Lifetime Criminal Legal Involvement in U.S. Adults.

Authors:  Laura C Hawks; Rebekah J Walker; Leonard E Egede
Journal:  Health Equity       Date:  2022-03-15

7.  Social adaptability and substance abuse: predictors of depression among hemodialysis patients?

Authors:  Paulo Roberto Santos; Francisco Plácido Nogueira Arcanjo
Journal:  BMC Nephrol       Date:  2013-01-15       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.